Past A/H Listings Performance - Most of the Deals Haven’t Done Much
China Tourism is gearing up to launch Hong Kong’s largest listing so far this year, with a reported deal size of around US$2-3bn. Ahead of its...
607 Views
Giant Biogene Pre-IPO - The Negatives - Co-Founders Have Already Cashed in US$1bn+
Giant Biogene (GB) aims to raise around US$500m in its Hong Kong IPO. It is the largest recombinant collagen based products maker in China.
558 Views
Pinduoduo: Community Group Buying Is Facing Multiple Challenges
With QoQ revenue growth at a standstill and sales and marketing cost cutting almost fully exhausted, we think the current consensus expectations...
461 Views
Smartkarma Originals
Dealshare Tearsheet - Social Commerce For the Masses
India Unicorn Series: We profile India's social commerce platform for the masses "Dealshare". The model and execution are interesting, with...
551 Views
Legend Biotech Follow-On - A Little Opportunistic. Last Deal Did Well, After a Large Correction
Legend Biotech Corp (LEGN US), a non-wholly owned subsidiary of Hong Kong-listed Genscript Biotech (1548 HK), is planning to raise up to US$250m in...
430 Views